Regarding the pricing of the corona virus vaccine developed by Pfizer and Biontech. A statement came from Pfizer CEO Albert Bourla. Bourla said that the pricing of the vaccine will vary by country. He said that they would give the vaccine to Africa without a profit.
With the introduction of the coronavirus vaccine developed by Pfizer and Biontech and called BNT162b2 in some countries. Countries entered the race for vaccination.
Making a statement about the price of the vaccine, Pfizer CEO Albert Bourla stated that the price of the vaccine will vary from country to country.
Pfizer Inc has decided to price the COVID-19 vaccine candidate BNT162b2 COVID-19 according to the country’s GDP. Albert Bourla, Chief Executive Officer of the American pharmaceutical company, spoke at a virtual press conference organized by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).
Stating that the price of the vaccine will vary from country to country, Bourla said; “The basis of our price is that we quickly make the vaccine available to everyone.
We have a tiered pricing. We demanded a higher price from developed countries and a lower price than that of developing countries.
“They will also pay non-high prices to developed countries,” Bourla said. The vaccine will be given to the USA at the price of 19.5 dollars, which is an average meal for a person ”
Stating that the company is in negotiations with various governments to send the vaccine, Bourla. He also stated that they are working on the issue of keeping vaccines at -70 degrees and focusing on a new formulation in this regard.